Epstein-Barr viral load measurement as a marker of EBV-related disease

Hongxin Fan; Margaret L. Gulley

doi:10.1054/modi.2001.29161

Epstein-Barr viral load measurement as a marker of EBV-related disease

Hongxin Fan, Margaret L. Gulley

Pathology

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Abstract

Epstein-Barr virus (EBV) is associated with a wide variety of benign and neoplastic diseases. EBV viral load assays that may prove useful in rapid assessment of disease status are now available. The two most common approaches to viral load measurement are quantitative, competitive PCR, and real-time PCR. Laboratory studies have shown that these assays are sensitive and specific for measuring EBV DNA in blood samples. Clinical investigations suggest a role for viral load measurement in predicting and monitoring EBV-associated tumors, including nasopharyngeal carcinoma, post-transplant lymphoproliferative disorder, Hodgkin's disease, and AIDS-related lymphoma. These new laboratory tools show promise in improving clinical management of affected patients.

Original language	English (US)
Pages (from-to)	279-289
Number of pages	11
Journal	Molecular Diagnosis
Volume	6
Issue number	4
DOIs	https://doi.org/10.1054/modi.2001.29161
State	Published - Jan 1 2001

Keywords

Infectious mononucleosis
Nasopharyngeal carcinoma
Post-transplant lymphoproliferation
Quantitative PCR

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1054/modi.2001.29161

Fingerprint Dive into the research topics of 'Epstein-Barr viral load measurement as a marker of EBV-related disease'. Together they form a unique fingerprint.

Cite this

@article{8dc614ca28da4fcfb73fd3e5ad5eddcb,

title = "Epstein-Barr viral load measurement as a marker of EBV-related disease",

abstract = "Epstein-Barr virus (EBV) is associated with a wide variety of benign and neoplastic diseases. EBV viral load assays that may prove useful in rapid assessment of disease status are now available. The two most common approaches to viral load measurement are quantitative, competitive PCR, and real-time PCR. Laboratory studies have shown that these assays are sensitive and specific for measuring EBV DNA in blood samples. Clinical investigations suggest a role for viral load measurement in predicting and monitoring EBV-associated tumors, including nasopharyngeal carcinoma, post-transplant lymphoproliferative disorder, Hodgkin's disease, and AIDS-related lymphoma. These new laboratory tools show promise in improving clinical management of affected patients.",

keywords = "Infectious mononucleosis, Nasopharyngeal carcinoma, Post-transplant lymphoproliferation, Quantitative PCR",

author = "Hongxin Fan and Gulley, {Margaret L.}",

year = "2001",

month = jan,

day = "1",

doi = "10.1054/modi.2001.29161",

language = "English (US)",

volume = "6",

pages = "279--289",

journal = "Molecular Diagnosis and Therapy",

issn = "1177-1062",

publisher = "Adis International Ltd",

number = "4",

}

TY - JOUR

T1 - Epstein-Barr viral load measurement as a marker of EBV-related disease

AU - Fan, Hongxin

AU - Gulley, Margaret L.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Epstein-Barr virus (EBV) is associated with a wide variety of benign and neoplastic diseases. EBV viral load assays that may prove useful in rapid assessment of disease status are now available. The two most common approaches to viral load measurement are quantitative, competitive PCR, and real-time PCR. Laboratory studies have shown that these assays are sensitive and specific for measuring EBV DNA in blood samples. Clinical investigations suggest a role for viral load measurement in predicting and monitoring EBV-associated tumors, including nasopharyngeal carcinoma, post-transplant lymphoproliferative disorder, Hodgkin's disease, and AIDS-related lymphoma. These new laboratory tools show promise in improving clinical management of affected patients.

AB - Epstein-Barr virus (EBV) is associated with a wide variety of benign and neoplastic diseases. EBV viral load assays that may prove useful in rapid assessment of disease status are now available. The two most common approaches to viral load measurement are quantitative, competitive PCR, and real-time PCR. Laboratory studies have shown that these assays are sensitive and specific for measuring EBV DNA in blood samples. Clinical investigations suggest a role for viral load measurement in predicting and monitoring EBV-associated tumors, including nasopharyngeal carcinoma, post-transplant lymphoproliferative disorder, Hodgkin's disease, and AIDS-related lymphoma. These new laboratory tools show promise in improving clinical management of affected patients.

KW - Infectious mononucleosis

KW - Nasopharyngeal carcinoma

KW - Post-transplant lymphoproliferation

KW - Quantitative PCR

UR - http://www.scopus.com/inward/record.url?scp=0035671576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035671576&partnerID=8YFLogxK

U2 - 10.1054/modi.2001.29161

DO - 10.1054/modi.2001.29161

M3 - Article

C2 - 11774193

AN - SCOPUS:0035671576

VL - 6

SP - 279

EP - 289

JO - Molecular Diagnosis and Therapy

JF - Molecular Diagnosis and Therapy

SN - 1177-1062

IS - 4

ER -